| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |